SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories
Divis Laboratories
BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 17:00
1846.45
6.3 (0.34%)
VOLUME 17,860
LIVE
NSE
May 22, 17:00
1852.95
11.6 (0.63%)
VOLUME 217,903
News on Divis Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Infosys, Divis Laboratories, UPL: Sudarshan Sukhani 

2.45 pm | 18 May 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Infosys, UPL and Divis Laboratories....

Go long in Divis Laboratories: Gaurav Bissa 

3.19 pm | 14 May 2015 |  Source: CNBC-TV18

Gaurav Bissa, Derivatives Analyst at LKP Securities recommends going long in Divis Laboratories for a target of Rs 1840-1850....

Divis Laboratories' FY15 results on May 23, 2015

12.23 pm | 12 May 2015 |  Source: Moneycontrol.com

Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 23, 2015, to consider and approve ...

Sell Divis Laboratories, Strides Arcolab: Manoj Murlidharan 

11.04 am | 07 May 2015 |  Source: CNBC-TV18

Manoj Murlidharan of Religare Securities recommends selling Divis Laboratories and Strides Arcolab....

Here are a few top trading ideas from Manoj Murlidharan 

9.47 am | 07 May 2015 |  Source: CNBC-TV18

Watch the interview of Manoj Murlidharan of Religare Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and ...

Stock market prediction for April 20-24: Satish Gupta

8.54 am | 20 Apr 2015 |  Source: Moneycontrol.com

Pharma sector will continue getting strong astrological support. Buy Cipla, Glenmark Pharma, Sun Pharma, Divis Lab, Ajanta Pharma, Wockhardt etc, says...

See 10-15% upside in midcap pharma space: Vineet Bhatnagar 

11.43 am | 16 Apr 2015 |  Source: CNBC-TV18

Vineet Bhatnagar - MD at Phillip Capital expects 10-15 percent upside in midcap pharma stocks including Glenmark Pharma, Divis Laboratories, Torrent P...

Nifty may not hit 9K in a hurry; like Glenmark: PhillipCap 

11.12 am | 16 Apr 2015 |  Source: CNBC-TV18

Going ahead, Vineet Bhatnagar, managing director, Phillip Capital expects refinery, oil marketing companies and ONGC to show strong upward moves. He a...

Buy Divis Labs, Colgate Palmolive March Futs: ICICIdirect

2.55 pm | 16 Mar 2015 |  Source: Moneycontrol.com

ICICIdirect.com has recommended to buy Divis Laboratories March Future and Colgate Palmolive March Future for target of Rs 1970 and Rs 2280 respective...

Motilal Oswal neutral on Divis Laboratories

5.48 pm | 19 Feb 2015 |  Source: Moneycontrol.com

Motilal Oswal has maintained a 'Neutral' rating on Divis Laboratories with a target price of Rs 1910, in its research report dated January 31, 2015....

11 stocks you should keep an eye on: Emkay

3.53 pm | 11 Feb 2015 |  Source: Moneycontrol.com

Emkay has come out with its 11 stock picks report. The research firm has recommended to buy Jagran Prakashan, PVR, UPL, GSK Consumer; accumulate Shopp...

Buy Divis Labs; target of Rs 2050: ICICIdirect

3.53 pm | 15 Jan 2015 |  Source: Moneycontrol.com

ICICIdirect.com has recommended to buy Divis Laboratories in the range of Rs 1710-1735 for the target price of Rs 2050 with a stop loss of Rs 1556, in...

Begin New Year with these 10 best blue-chip stocks: Karvy

1.04 pm | 02 Jan 2015 |  Source: Moneycontrol.com

Karvy has come out with its Wealth Maximizer report for 2015. "Top ten Largecap picks in the Wealth Maximizer (for a time frame of 9-12 months) are As...

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.